ABSTRACT
INTRODUCTION
Schistosomiasis is the second most prevalent tropical disease in Africa after malaria and is of great public health and socio-economic importance in the developing world (Engles et al., 2002) . Schistosoma mansoni-causative agent of intestinal bilharzia-originated in Africa but was carried to South America, with the slave trade; it is transmitted by snails of the genus Biomphalaria snails (link). Schistosoma haematobium which causes urinary bilharzia is transmitted by snails of the species Bulinus, which inhabit less permanent water bodies (Rosset al., 2002) . The third major species of schistosome is S. japonicum, used to be widespread in Japan, China and the Far East and was the cause of widespread and gross morbidity and mortality. It affects not only man but also domestic and wild animals. S. japonicum is transmitted by an amphibious snail (species Oncomelania) which makes snail control relatively easy. There are two minor species of schistosomiais, First, S. intercalatum which is confined to West Africa and lives in the mesenteric vessels of man causing abdominal pain and bloody diarrhea. The second is S. mekongi, which is another form of intestinal schistosoma is found predominantly in Southeast Asia. The main reservoir for this species is dogs (Reich and Fenwick, 2001 ) as shown in Table 1 .
LIFE CYCLE OF SCHISTOSOME
Schistosomiasis is a disease which is caused by various human-pathogenic trematodes belonging to the genus Schistosoma, more than 200 million people at present suffer from disease due to this parasitosis At the moment about 500-600 million people in 74 countries, that is approximately a tenth of the world population, are living with the risk of infection. Once in the human body, the cercariae develop further to schistosomula, schistosomes have separate sexes) (Urbani et al., 1997) . Afterwards, the worms migrate upstream to their final destination within the venules of the bladder, rectum or colon. (Capron et al., 1995) . Present study promises to improve the understanding of cytokine interaction in the development of pathology and immunity, looking for a way to induce maximum levels of immunity without enhancing egg-associated reactions (Doenhoff, 1998) . Fasciola and Schistosoma worm antigens mixed with or without saponin as well as saponin alone succeeded to protect mice against S. mansoni infection with more potent effect of the separately saponin and Fasciola antigens. This protection is achieved by reduction in total, male and female worms as well as the levels of toxins elaborated by them. This proved the role of these antigens in eliminating the product of oxidative stress and assistance in immune-mediated destruction of eggs that ameliorate the histopathological picture of the liver cells and preserve its function (Maghraby et al., 2010a) .Schistosoma mansoni egg granuloma size reduction in liver section after vaccination with Fassiola or Schistosoma egg, in addition to Fassiola or Schistosoma egg with saponin antigens (Maghraby et al., 2010b) .
As recombinant DNA techniques cannot yet be utilized to produce carbohydrate antigens it is more useful to focus on antigens which are predominantly of protein nature. In addition, carbohydrate antigens often cross-react with egg antigens and augment the risk of activating granulomatous reactions. The comparison between the relatively small granulomas of chronic schistosomiasis and those associated with early infection (Von Lichtenberg, 1987) and the fact that most anti-carbohydrate antibodies eventually become down-regulated (Omer- Ali et al., 1989) , also emphasizes the usefulness of protein antigens.
The list of published schistosome antigens, now numbering in excess of one hundred, comes from various parasite stages with the schistosomulum surface membrane being the preferential target (McKerrow et al., 1985) .
Therapeutic agents
Chemotherapy: This is the most effective method for reducing the infection rates of schistosomiasis. Access to very effective drug in the last three decades has resulted in reducing the prevalence and morbidity of the disease in many areas of the world and reducing the public health importance of Schistosomisis in some countries (Doenhoff, 1998) .
Treatment of infected cases provides the most effective short-term results in control of schistosomiasis (Castro et al., 2002) . It also reduces morbidity and rate of the transmission.
Treatment of cases as a control method require proper planning such as defining objectives of treatment, using the most reliable case finding method, selection of appropriate drug, section of the population to be treated, correct dosage schedule and having adequate information on the drug and its side-effects (Cioli et al., 1995) . Because case detection is the first approach for planning chemotherapy and selection of most effective chemotherapy, diagnostic techniques available will be described first. Although, several drugs were used for treatment of Schistosomiasis in the past, now only a few drugs are used. Introduction of praziquantel has transformed the treatment of schistosomiasis (Colley et al., 2001 ). This drug is effective, generally in a single dose, against all species of the parasite. Other drugs include metrifonate, which is active againstS. haematobium and oxamniquine, which is effective against S. mansoni.
Synthetic antischistosomal drugs
Praziquantel: Praziquantel is a heterocyclic pyrazine-isoquinoline and is highly active against a wide range of trematodes, including all species of schistosome pathogenic to humans Praziquantel with a single dose of 40 mg kg -1 is effective. In the treatment of all forms of schistosomiasis in both adults and children. The cure rate is usually 60-90% with egg reductions of 90-95% in those not cured (Andrews, 1981) Praziquantel although generally well olerated, it may induce abdominal discomfort, bloody diarrhoea, nausea, headache, dizziness, urticaria and rectal bleeding in patients with heavy worm loads (Beck et al., 2001 ).
Resistance to praziquantel in the treatment of schistosomiasis has been reported from Egypt where the drug has been used aggressively for more that 10 years (Doenhoff et al., 2000; El-Banhawey et al., 2007; El-Ansary et al., 2007) . There are some reports of the possibility of resistance of some strains of schistosomiasis to praziquantel (Fallon et al., 1995; Mandour et al., 1990) some believe this resistance does not exist (Ismail et al., 1999) .
Metrifonate:
Metrifonate is an organophosphorus compound originally used as an insecticide. It is well tolerated and is very effective in the treatment of S.
haematobium mostly in mass chemotherapy programs (Danso-Appiah and De-Vlas, 2002 ).
Because of the lower coast of metrifonate and the low side-effects, this drug is recommended for the mass-treatment of school children. Even when viable worms remain, egg counts after one year is reduced to less than 20% of pretreatment levels.
The effective dose in adults and children is 7.5 mg kg -1 on given three times at intervals of two weeks (Feldmeier and Chitsulo, 1999) . Because of the side effect of this drug, metrifonate
should not be used for mass chemotherapy in communities recently exposed to insecticides or other agricultural chemicals with an anticholinesterase action. After administration, of metrifonate abdominal pain, nausea, vomiting, diarrhoea, headache and vertigo may occur.
Oxamniquine: Oxamniquine, a tetrahydroquinoline derivative is used for the treatment of schistosomiasis due to S. mansoni both in the acute stage and in patients with hepatosplenic involvement. The effective dose varies between 15 and 60 mg kg -1 given over two to three days (Botros et al., 1989) . Since oxamniquine has been known to cause seizures. Epileptic patients should remain under observation for several hours following treatment. It is used extensively in control programs in South America. Some strains of S.
mansoni are resistant to this drug. Side effects of oxamniquine are dizziness, drowsiness, headache and raise of the levels of serum transaminases in some patients (Fallon and Doenhoff, 1994) .
Artemisinin: There is some concern that large-scale use of an artemisinin derivative against Schistosomiasis might select for resistance in malaria parasites. Although, this risk appears to be low, mainly because of the very short elimination half-lives of artemisinins (Genovese et al., 2000; N'Goran et al., 1997 N'Goran et al., , 2003 , at present, use of these combinations
should not be recommended in areas where both schistosome and malaria parasites coexist (Hastings et al., 2002; Xiao et al., 2002) .
Virulence mechanisms contributing to the disease process:
In infection by S.
mansoni, the major pathologic changes are not caused by the adult worm itself but by eggs which do not reach the intestinal lumen, but instead, become trapped in other body tissues. At these sites, areas of local inflammation are produced, cumulating in the formation of granulomas around eggs (Giboda and Smith, 1994) . The eggs of Schistosomoes are lethal to a human's body system. When the body detects these eggs, an inflammatory reaction is triggered. Instead of killing the eggs, the eggs gain a protein capsule from the inflammatory cells, which in turn regulate its ovulation. The encapsulated eggs cause liver damage. Eggs undetected by the body's defense system also harm the body. The embryos in the un-capsulated eggs release a toxin that damages the liver (Reynolds et al., 2002) . The formation of granuloma around schistosome eggs in the liver and the intestine is the major cause of pathology in schistosome infections. Granuloma and the subsequent fibrosis in the liver appear to be primarily responsible for mortality and morbidity by this highly endemic parasitic disease (El-Banhawey et al., 2007) . Ultrasound is used for detection of complications of infection in animals resulted in a marked decrease in liver glycogen (Akpinar and Metin, 1999) . Visible to the human eye are the enlargement of the liver and spleen. Once symptoms have been noticed treatment can occur. In vivo microscopy revealed in addition to these lesions, dilatation and sacculation of sinusoids. These lesions were associated with varying degrees of reduction of blood flow due to schistosomules (El-Banhawy et al., 2007; Aly and Hamed, 2006) . Enlargement of the spleen and especially liver will continue resulting development of the arteriovenous shunts in the lever. Ascites of the liver and esophageal varices may proceed. Among sever cases hepatomegaly and enlargement of the spleen are found in high number of cases (Talaat and Miller, 1998) . Other clinical manifestations of chronic schistosomiasis include core pulmonale due to egg deposition in the lungs and subsequent development of pulmonary hypertension. Pulmonary complications of S. mansoni infection manifest with bronchopulmonary symptoms (Akpinar and Metin, 1999) .
Total protein was reduced in bilharzail infection. This could be attributed to cellular damage caused by parasite toxins. The main fraction of total protein content is albumins and the reduction in total protein may be due to reduction in albumin fraction level that in turn may be result from decrease anabolism or increase catabolism; hence, malnutrition and/or malabsorption may contribute to decrease biosyntheses of albumin (El-Fakahani et al., 1993; Rizk et al., 2000; El-Ansary et al., 2007) . The significant decrease in total protein is mainly due to increase in messenger RNA degradation which is the possible cause for the hypoalbuminemia of murine schistosomiasis (Metwally et al., 1990) . Perioval granulomas in the liver lead to fibrosis.
The enlargement of the spleen may be attributed to the direct deposition of the eggs in that organ or due to inflammatory and fibrotic reactions in the splenic host that are the main factors responsible for obstruction to portal venous flow which its major consequence is splenomegaly, in histopathological examination, congestion was evident in sinusoids of red pulp and lymphoid follicles (White pulp) were enlarged. This marked congestion in red pulp showed evidence of haemorrhages (Aly and Hamed, 2006) .
Natural product:
The recent approach on the development of new drugs from natural products for treatment of human diseases especially in developing countries which still rely on traditional medicinal for their primary health care based largely from various species of plants ( WHO, 2002) .
There is still intensive search for effective anti-schistosomal drugs with minimal side effects (El-Banhawey et al., 2007) . Plants are the basis of traditional medicine systems that have been in existence for thousands of years and continue into modern times (Jellin et al., 2000) . The antibiotic penicillin being the most well known. In addition to plants and microbes there has been growing interest in the role of animals as sources of medicines including products derived from frogs and from marine snails (Duke, 2002) . 
CONCLUSION
In conclusion, the author proposed that natural product extracts with non-toxic medicinal properties should be explored for possible intervention in schistosomiasis as a disease involving impairment of metabolism of infected subjects. These inspire more hope for reducing the intensity of schistosomal infection by reduction in worm burden, ova count, granuloma size and number leading to improvement in histopathological picture of liver, spleen and kidney as a result of reducing inflammatory and fibrotic reactions of schistosoma.
